May Momentum Tuesdays
Featuring Research Updates from Alain Moreau, PhD
Welcome back to another installment of May Momentum Tuesdays, a webcast series where you will hear interviews with Directors of OMF supported Collaborative Research Centers (CRC)s.
Today, Alain Moreau, PhD, Director of the OMFCA supported Collaborative Research Center at the University of Montréal, talks about a new test to discriminate Fibromyalgia from ME/CFS, insights from Long COVID research, and more.
*Be sure to turn on YouTube’s closed captions to watch with subtitles!*
Please consider supporting these research efforts by contributing to OMFCA’s May Momentum campaign today:
More About Alain Moreau, Phd
Dr. Alain Moreau is a Full Professor in the Faculty of Dentistry (Stomatology Department), cross-appointed to the Biochemistry and Molecular Medicine Department in the Faculty of Medicine at Université de Montréal.
He served as Director of Research and Chief Scientific Officer of Sainte-Justine University Hospital (2013-2016). He is currently Director of The Network for Canadian Oral Health Research (NCOHR), and he serves on the Advisory Board of the Institute of Musculoskeletal Health and Arthritis of The Canadian Institutes of Health Research (CIHR).
Dr. Moreau was appointed Director of the Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis (ICanCME) Research Network, another national research network funded by CIHR. He is an internationally recognized expert on the molecular genetics of pediatric scoliosis. His discoveries led to multiple peer-reviewed papers, international conferences as a guest speaker, several awards as well as 60 patents covering innovative diagnostic tests and therapeutic molecules.
Dr. Moreau is the co-founder and Chief Scientific Officer of Inception Therapeutic Inc., a start-up based in Montreal developing diagnostic tests for primary osteoarthritis and new disease-modifying osteoarthritis drugs. Moreau’s primary research interests also target other complex adult diseases such as osteoporosis and Myalgic Encephalomyelitis.
May Momentum Tuesdays Schedule
This webcast series is a special effort to update the community on the progress underway at the OMF supported Collaborative Research Centers (CRC)s. Each Tuesday we will share a new interview with a CRC Director.
*Please note a change in the schedule: We are delighted to be sharing an interview with Ronald W. Davis, PhD, on May 31st!
May 3, 2022 – Jonas Bergquist, MD, PhD, OMF Chief Medical Officer,
Director, Uppsala CRC. Video now available
May 10, 2022 – Alain Moreau, PhD, Director, Montreal CRC. Video now available.
May 17, 2022 – Christopher W. Armstrong, PhD, Director, Melbourne Collaborative
May 24, 2022 – Wenzhong Xiao, PhD, Co-Director, The Ronald G. Tompkins Harvard CRC, Director, Computational Research Center for Complex Diseases & David Systrom, MD, Co-Director, The Ronald G. Tompkins Harvard CRC
May 31, 2022 – *NEW!* Ronald W. Davis, PhD, Chair of Open Medicine Foundation Scientific Advisory Board, Director, ME/CFS Stanford Collaborative Research
Want to take your donation to the next level?
Please consider becoming a monthly donor during May Momentum! Your monthly contribution ensures that OMF has the resources necessary to fulfill our mission to end multisystem chronic complex diseases (msCCD)
Can’t donate? No problem! There are many ways you can join in on the momentum. We invite you to find an option that works best for you:
Thank you for your support.
We are so grateful to have you as part of our OMFCA Family! ♥